BLINKLAB LIMITED - Announcements

2.26%

65.0¢

Market Cap $101.6M

Technology Software - Application

BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and... BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutionise neurodevelopmental condition diagnosis like ASD and ADHD. Born from extensive research at Princeton University, BlinkLab offers early detection and effective intervention solutions through its smartphone-based diagnostic platform. The company is committed to improving mental health care globally, starting with the youngest patients.More

Announcements

Filter Results

All Price Sensitive Only

BB1	Therapy Evaluation for Neurodevelopmental Conditions		09:46	228.55KB	Share
BB1	BB1 to present at Stocks in the Vines Investor Access Day		14/05/26	266.37KB	Share
BB1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/26	462.22KB	Share
BB1	Section 708A Notice		23/04/26	193.45KB	Share
BB1	Application for quotation of securities - BB1		23/04/26	15.75KB	Share
BB1	BlinkLab Invited to Present at Ignite Investment Summits		17/04/26	11.22MB	Share
BB1	Update - Proposed issue of securities - BB1		16/04/26	19.7KB	Share
BB1	Proposed issue of securities - BB1		16/04/26	19.52KB	Share
BB1	BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid	PRICE SENSITIVE	16/04/26	220.98KB	Share
BB1	Trading Halt	PRICE SENSITIVE	14/04/26	193.71KB	Share
BB1	Application for quotation of securities - BB1		07/04/26	14.27KB	Share
BB1	Notice of Release of Escrowed Securities		26/03/26	231.96KB	Share
BB1	Validation Program Commences-FDA 510(k) - First Participant	PRICE SENSITIVE	24/03/26	384.97KB	Share
BB1	Morocco's Nationwide Government-Funded Autism Screening	PRICE SENSITIVE	23/03/26	320.58KB	Share
BB1	Trading Halt	PRICE SENSITIVE	19/03/26	299.77KB	Share
BB1	Clinical Trial Network for Pivotal FDA Study Complete	PRICE SENSITIVE	16/03/26	407.54KB	Share
BB1	BlinkLab Forms Partnership with SHANK2 Autism Foundation		13/03/26	226.76KB	Share
BB1	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/26	605.26KB	Share
BB1	Notification regarding unquoted securities - BB1		13/02/26	16.15KB	Share
BB1	BB1 Expands Pivotal FDA Trial Network to Nine Elite Sites		12/02/26	399.94KB	Share
BB1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/26	511.75KB	Share
BB1	BB1 Presents at Simons Foundation Autism Research Initiative		23/01/26	308.68KB	Share
BB1	BlinkLab Receives $822k R&D Tax Incentive Refund		08/01/26	190.76KB	Share
BB1	High-Profile Journal Publication Validates BB1 Technology	PRICE SENSITIVE	05/01/26	273.83KB	Share
BB1	Initial Director's Interest Notice		19/12/25	249.84KB	Share
BB1	Final Director's Interest Notice		19/12/25	209.52KB	Share
BB1	Appointment of Managing Director and Board Changes	PRICE SENSITIVE	18/12/25	250.83KB	Share
BB1	Section 708A Notice		04/12/25	154.38KB	Share
BB1	Application for quotation of securities - BB1		04/12/25	15.69KB	Share
BB1	Updated Corporate Presentation		02/12/25	8.29MB	Share
BB1	Section 708A Notice		26/11/25	154.41KB	Share
BB1	Application for quotation of securities - BB1		26/11/25	15.7KB	Share
BB1	Section 708A Notice		19/11/25	161.02KB	Share
BB1	Application for quotation of securities - BB1		19/11/25	15.69KB	Share
BB1	Rush University Medical Center joins Pivotal US Autism Trial		13/11/25	298.63KB	Share
BB1	Section 708A Notice		10/11/25	160.11KB	Share
BB1	Application for quotation of securities - BB1		10/11/25	15.69KB	Share
BB1	Results of Annual General Meeting		07/11/25	119.54KB	Share
BB1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/25	690.12KB	Share
BB1	Investor Webinar		22/10/25	128.28KB	Share
BB1	Pilot Study Confirms High Diagnostic Accuracy & Readiness	PRICE SENSITIVE	22/10/25	333.23KB	Share
BB1	Trading Halt	PRICE SENSITIVE	20/10/25	196.97KB	Share
BB1	Section 708A Notice		15/10/25	160.08KB	Share
BB1	Application for quotation of securities - BB1		15/10/25	15.69KB	Share
BB1	Section 708A Notice		14/10/25	236.06KB	Share
BB1	Application for quotation of securities - BB1		14/10/25	15.69KB	Share
BB1	Letter to Shareholders & Proxy Form		22/09/25	194.16KB	Share
BB1	Notice of AGM & Proxy Form		22/09/25	394.3KB	Share
BB1	The Vanderbilt Kennedy Center Onboarded		18/09/25	536.41KB	Share
BB1	The University of Missouri - Thompson Center - Engaged		17/09/25	497.47KB	Share
BB1	Date of AGM & Closing Date for Director Nominations		11/09/25	216.63KB	Share
BB1	Appendix 4G & Corporate Governance Statement		28/08/25	582.53KB	Share
BB1	2025 Annual Report & Appendix 4E	PRICE SENSITIVE	28/08/25	1.54MB	Share
BB1	Two Additional Strategic Partnerships Advance FDA Submission		26/08/25	522.01KB	Share
BB1	University of Pennsylvania Perelman School of Med Onboarded		21/08/25	291.05KB	Share
BB1	Presentation - TechKnow Invest Roadshow Conference		19/08/25	8.32MB	Share
BB1	Section 708A Notice		13/08/25	112.35KB	Share
BB1	Application for quotation of securities - BB1		13/08/25	15.69KB	Share
BB1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	25/07/25	994.17KB	Share
BB1	Change of Director's Interest Notice x4		11/07/25	4.27MB	Share
BB1	Section 708A Notice		09/07/25	491.97KB	Share
BB1	Notification regarding unquoted securities - BB1		09/07/25	19.05KB	Share
BB1	Notification regarding unquoted securities - BB1		09/07/25	18KB	Share
BB1	Application for quotation of securities - BB1		09/07/25	16.3KB	Share
BB1	UNMC Engaged as Second Site in Main Phase of FDA510(k) Study		08/07/25	276.59KB	Share
BB1	Section 708A Notice		02/07/25	451.33KB	Share
BB1	Application for quotation of securities - BB1		02/07/25	15.66KB	Share
BB1	Results of General Meeting		30/06/25	216KB	Share
BB1	Section 708A Notice		30/06/25	452.17KB	Share
BB1	Application for quotation of securities - BB1		30/06/25	15.66KB	Share
BB1	US Ethics Approval Received for the Main Phase of FDA510(k)	PRICE SENSITIVE	30/06/25	363.35KB	Share
BB1	Response to ASX Price and Volume Query	PRICE SENSITIVE	24/06/25	727.85KB	Share
BB1	Change in substantial holding		20/06/25	198.62KB	Share
BB1	Change in substantial holding		20/06/25	199.26KB	Share
BB1	Ceasing to be a substantial holder		19/06/25	194.36KB	Share
BB1	Ceasing to be a substantial holder		19/06/25	193.66KB	Share
BB1	Letter to Shareholders & Proxy Form		30/05/25	476.69KB	Share
BB1	Notice of General Meeting & Proxy Form		30/05/25	612.01KB	Share
BB1	BlinkLab Engages First Clinical Site for Main Study Phase		22/05/25	363.09KB	Share
BB1	Change of Director's Interest Notice (RH)		20/05/25	1.1MB	Share
BB1	Section 708A Notice		08/05/25	451.01KB	Share
BB1	Application for quotation of securities - BB1		08/05/25	15.78KB	Share
BB1	Proposed issue of securities - BB1		01/05/25	19.2KB	Share
BB1	Successful Placement of A$7.66M to Underpin Growth Strategy	PRICE SENSITIVE	01/05/25	435.45KB	Share
BB1	Trading Halt	PRICE SENSITIVE	29/04/25	270.35KB	Share
BB1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/25	1.25MB	Share
BB1	BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial	PRICE SENSITIVE	01/04/25	369.71KB	Share
BB1	Trading Halt	PRICE SENSITIVE	31/03/25	271.63KB	Share
BB1	Pause in Trading	PRICE SENSITIVE	31/03/25	112.78KB	Share
BB1	Brokers meet Biotech Presentation		20/03/25	12.59MB	Share
BB1	Blinklab Expands Autism Diagnostics into Adults		19/03/25	303.22KB	Share
BB1	US Autism Diagnostic Study Commences with First Child Tested	PRICE SENSITIVE	12/03/25	366.65KB	Share
BB1	Section 708(A) Notice		27/02/25	464.75KB	Share
BB1	Application for quotation of securities - BB1		27/02/25	15.55KB	Share
BB1	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/25	1.75MB	Share
BB1	North Shore Pediatric Therapy in Chicago joins Study	PRICE SENSITIVE	10/02/25	388.39KB	Share
BB1	BlinkLab Initiates its First US-based Clinical Site		05/02/25	391.5KB	Share
BB1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	1.39MB	Share
BB1	Change of Director's Interest Notice		14/01/25	695.29KB	Share
BB1	Change of Director's Interest Notice		14/01/25	1.1MB	Share

BB1 Therapy Evaluation for Neurodevelopmental Conditions
09:46		228.55KB	Share
BB1 BB1 to present at Stocks in the Vines Investor Access Day
14/05/26		266.37KB	Share
BB1 Quarterly Activities/Appendix 4C Cash Flow Report
30/04/26	PRICE SENSITIVE	462.22KB	Share
BB1 Section 708A Notice
23/04/26		193.45KB	Share
BB1 Application for quotation of securities - BB1
23/04/26		15.75KB	Share
BB1 BlinkLab Invited to Present at Ignite Investment Summits
17/04/26		11.22MB	Share
BB1 Update - Proposed issue of securities - BB1
16/04/26		19.7KB	Share
BB1 Proposed issue of securities - BB1
16/04/26		19.52KB	Share
BB1 BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid
16/04/26	PRICE SENSITIVE	220.98KB	Share
BB1 Trading Halt
14/04/26	PRICE SENSITIVE	193.71KB	Share
BB1 Application for quotation of securities - BB1
07/04/26		14.27KB	Share
BB1 Notice of Release of Escrowed Securities
26/03/26		231.96KB	Share
BB1 Validation Program Commences-FDA 510(k) - First Participant
24/03/26	PRICE SENSITIVE	384.97KB	Share
BB1 Morocco's Nationwide Government-Funded Autism Screening
23/03/26	PRICE SENSITIVE	320.58KB	Share
BB1 Trading Halt
19/03/26	PRICE SENSITIVE	299.77KB	Share
BB1 Clinical Trial Network for Pivotal FDA Study Complete
16/03/26	PRICE SENSITIVE	407.54KB	Share
BB1 BlinkLab Forms Partnership with SHANK2 Autism Foundation
13/03/26		226.76KB	Share
BB1 Half Yearly Report and Accounts
25/02/26	PRICE SENSITIVE	605.26KB	Share
BB1 Notification regarding unquoted securities - BB1
13/02/26		16.15KB	Share
BB1 BB1 Expands Pivotal FDA Trial Network to Nine Elite Sites
12/02/26		399.94KB	Share
BB1 Quarterly Activities/Appendix 4C Cash Flow Report
30/01/26	PRICE SENSITIVE	511.75KB	Share
BB1 BB1 Presents at Simons Foundation Autism Research Initiative
23/01/26		308.68KB	Share
BB1 BlinkLab Receives $822k R&D Tax Incentive Refund
08/01/26		190.76KB	Share
BB1 High-Profile Journal Publication Validates BB1 Technology
05/01/26	PRICE SENSITIVE	273.83KB	Share
BB1 Initial Director's Interest Notice
19/12/25		249.84KB	Share
BB1 Final Director's Interest Notice
19/12/25		209.52KB	Share
BB1 Appointment of Managing Director and Board Changes
18/12/25	PRICE SENSITIVE	250.83KB	Share
BB1 Section 708A Notice
04/12/25		154.38KB	Share
BB1 Application for quotation of securities - BB1
04/12/25		15.69KB	Share
BB1 Updated Corporate Presentation
02/12/25		8.29MB	Share
BB1 Section 708A Notice
26/11/25		154.41KB	Share
BB1 Application for quotation of securities - BB1
26/11/25		15.7KB	Share
BB1 Section 708A Notice
19/11/25		161.02KB	Share
BB1 Application for quotation of securities - BB1
19/11/25		15.69KB	Share
BB1 Rush University Medical Center joins Pivotal US Autism Trial
13/11/25		298.63KB	Share
BB1 Section 708A Notice
10/11/25		160.11KB	Share
BB1 Application for quotation of securities - BB1
10/11/25		15.69KB	Share
BB1 Results of Annual General Meeting
07/11/25		119.54KB	Share
BB1 Quarterly Activities/Appendix 4C Cash Flow Report
29/10/25	PRICE SENSITIVE	690.12KB	Share
BB1 Investor Webinar
22/10/25		128.28KB	Share
BB1 Pilot Study Confirms High Diagnostic Accuracy & Readiness
22/10/25	PRICE SENSITIVE	333.23KB	Share
BB1 Trading Halt
20/10/25	PRICE SENSITIVE	196.97KB	Share
BB1 Section 708A Notice
15/10/25		160.08KB	Share
BB1 Application for quotation of securities - BB1
15/10/25		15.69KB	Share
BB1 Section 708A Notice
14/10/25		236.06KB	Share
BB1 Application for quotation of securities - BB1
14/10/25		15.69KB	Share
BB1 Letter to Shareholders & Proxy Form
22/09/25		194.16KB	Share
BB1 Notice of AGM & Proxy Form
22/09/25		394.3KB	Share
BB1 The Vanderbilt Kennedy Center Onboarded
18/09/25		536.41KB	Share
BB1 The University of Missouri - Thompson Center - Engaged
17/09/25		497.47KB	Share
BB1 Date of AGM & Closing Date for Director Nominations
11/09/25		216.63KB	Share
BB1 Appendix 4G & Corporate Governance Statement
28/08/25		582.53KB	Share
BB1 2025 Annual Report & Appendix 4E
28/08/25	PRICE SENSITIVE	1.54MB	Share
BB1 Two Additional Strategic Partnerships Advance FDA Submission
26/08/25		522.01KB	Share
BB1 University of Pennsylvania Perelman School of Med Onboarded
21/08/25		291.05KB	Share
BB1 Presentation - TechKnow Invest Roadshow Conference
19/08/25		8.32MB	Share
BB1 Section 708A Notice
13/08/25		112.35KB	Share
BB1 Application for quotation of securities - BB1
13/08/25		15.69KB	Share
BB1 Quarterly Activities/Appendix 4C Cash Flow Report
25/07/25	PRICE SENSITIVE	994.17KB	Share
BB1 Change of Director's Interest Notice x4
11/07/25		4.27MB	Share
BB1 Section 708A Notice
09/07/25		491.97KB	Share
BB1 Notification regarding unquoted securities - BB1
09/07/25		19.05KB	Share
BB1 Notification regarding unquoted securities - BB1
09/07/25		18KB	Share
BB1 Application for quotation of securities - BB1
09/07/25		16.3KB	Share
BB1 UNMC Engaged as Second Site in Main Phase of FDA510(k) Study
08/07/25		276.59KB	Share
BB1 Section 708A Notice
02/07/25		451.33KB	Share
BB1 Application for quotation of securities - BB1
02/07/25		15.66KB	Share
BB1 Results of General Meeting
30/06/25		216KB	Share
BB1 Section 708A Notice
30/06/25		452.17KB	Share
BB1 Application for quotation of securities - BB1
30/06/25		15.66KB	Share
BB1 US Ethics Approval Received for the Main Phase of FDA510(k)
30/06/25	PRICE SENSITIVE	363.35KB	Share
BB1 Response to ASX Price and Volume Query
24/06/25	PRICE SENSITIVE	727.85KB	Share
BB1 Change in substantial holding
20/06/25		198.62KB	Share
BB1 Change in substantial holding
20/06/25		199.26KB	Share
BB1 Ceasing to be a substantial holder
19/06/25		194.36KB	Share
BB1 Ceasing to be a substantial holder
19/06/25		193.66KB	Share
BB1 Letter to Shareholders & Proxy Form
30/05/25		476.69KB	Share
BB1 Notice of General Meeting & Proxy Form
30/05/25		612.01KB	Share
BB1 BlinkLab Engages First Clinical Site for Main Study Phase
22/05/25		363.09KB	Share
BB1 Change of Director's Interest Notice (RH)
20/05/25		1.1MB	Share
BB1 Section 708A Notice
08/05/25		451.01KB	Share
BB1 Application for quotation of securities - BB1
08/05/25		15.78KB	Share
BB1 Proposed issue of securities - BB1
01/05/25		19.2KB	Share
BB1 Successful Placement of A$7.66M to Underpin Growth Strategy
01/05/25	PRICE SENSITIVE	435.45KB	Share
BB1 Trading Halt
29/04/25	PRICE SENSITIVE	270.35KB	Share
BB1 Quarterly Activities/Appendix 4C Cash Flow Report
28/04/25	PRICE SENSITIVE	1.25MB	Share
BB1 BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial
01/04/25	PRICE SENSITIVE	369.71KB	Share
BB1 Trading Halt
31/03/25	PRICE SENSITIVE	271.63KB	Share
BB1 Pause in Trading
31/03/25	PRICE SENSITIVE	112.78KB	Share
BB1 Brokers meet Biotech Presentation
20/03/25		12.59MB	Share
BB1 Blinklab Expands Autism Diagnostics into Adults
19/03/25		303.22KB	Share
BB1 US Autism Diagnostic Study Commences with First Child Tested
12/03/25	PRICE SENSITIVE	366.65KB	Share
BB1 Section 708(A) Notice
27/02/25		464.75KB	Share
BB1 Application for quotation of securities - BB1
27/02/25		15.55KB	Share
BB1 Half Yearly Report and Accounts
26/02/25	PRICE SENSITIVE	1.75MB	Share
BB1 North Shore Pediatric Therapy in Chicago joins Study
10/02/25	PRICE SENSITIVE	388.39KB	Share
BB1 BlinkLab Initiates its First US-based Clinical Site
05/02/25		391.5KB	Share
BB1 Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	1.39MB	Share
BB1 Change of Director's Interest Notice
14/01/25		695.29KB	Share
BB1 Change of Director's Interest Notice
14/01/25		1.1MB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 65.0¢		Change -0.015(2.26%)		Mkt cap ! $101.6M

Open	High	Low	Volume
67.0¢	69.5¢	65.0¢	118.6K

Buyers (Bids)

Vol.	Price($)
94827	65.0¢

Sellers (Offers)

Price($)	Vol.
65.5¢	42919

Last trade - 13.14pm 19/05/2026 (20 minute delay)

BB1 (ASX) Chart

BLINKLAB LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories